Transcranial Electric Stimulation for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

Transcranial Electric Stimulation for Health & Longevity

Created on 08/09/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

A faint electric current passed through the scalp to shift how easily parts of the brain respond. Cheap, portable, and free of serious injury across thousands of sessions. The clearest signal is for low mood, especially alongside medication. Smaller signals for chronic pain, sleeplessness, later-life anxiety, and memory in older adults. Benefit concentrates in those starting from a deficit. (Full Review)

Protocol

Standard prefrontal direct-current protocol for mood
2 mA, 30 min
Anode over left dorsolateral prefrontal cortex, cathode right. Home course: 5 sessions per week for 3 weeks, then 3 per week for 7 weeks; clinics compress to 10–20 consecutive weekday sessions.
Frequency-matched rhythmic protocol for memory
20 min daily, 4 days
Slower rhythms over the inferior parietal lobule for working memory, faster rhythms over the dorsolateral prefrontal cortex for long-term memory, through a focal multi-electrode array during a recall task.
Best time of day
Morning or early afternoon
Plasticity responses are largest when sleep pressure is low and are markedly blunted after sleep deprivation; evening excitatory stimulation risks delaying sleep onset. One session per day is the conservative and conventional arrangement.
Time to effect
Mood
2–4 weeks
Separation from sham, with the home trial's advantage accumulating over 10 weeks.
Memory
2–3 consecutive days
Measurable gains by the second to third consecutive day; gains from a four-day course still measurable at one month.
Insomnia
Within 2 weeks
Rapid improvement in sleep onset and total sleep time with nightly or weekday rhythmic current.

Benefits

Contraindications
  • Any implanted electronic device in or near the head (deep brain stimulator, vagus nerve stimulator, cochlear implant, cardiac pacemaker or defibrillator)
  • Metallic implants in the skull or intracranial space (aneurysm clips, shunts)
  • Broken, inflamed, or infected skin at the electrode sites
  • Specialist supervision rather than self-administration: active epilepsy or seizure within the past 12 months, bipolar disorder type I or type II, acute manic or mixed episode, stroke or traumatic brain injury within 90 days, active suicidal ideation, pregnancy, age under 18 outside a research setting
  • Caution: migraine with aura, uncontrolled hypertension above 180/110 mmHg, severe hepatic or renal impairment
Key Interactions
  • Sodium and calcium channel blockers (carbamazepine, lamotrigine, phenytoin, flunarizine, amlodipine)
  • NMDA receptor antagonists (dextromethorphan, memantine, ketamine)
  • NMDA receptor partial agonists (D-cycloserine)
  • Dopaminergic agents (levodopa, pramipexole, ropinirole, sulpiride, haloperidol, metoclopramide)
  • Serotonergic antidepressants (citalopram, escitalopram, sertraline)
  • Cholinergic and adrenergic agents (rivastigmine, donepezil, amphetamine-class stimulants)
  • Benzodiazepines and other GABA-A enhancers (lorazepam)
  • Over-the-counter agents (dextromethorphan, nicotine, caffeine, alcohol, topical scalp products)
  • Supplement interactions (high-dose magnesium, zinc, D-serine or glycine, racetams, alpha-GPC, citicoline, St John's wort, melatonin)
  • Additive interventions to account for (cognitive training, aerobic exercise, psychotherapy, transcranial magnetic stimulation, photobiomodulation, ultrasound neuromodulation)

Risk & Side Effects

  • High: Transient skin sensations at the electrode sites; headache and post-session fatigue
  • Medium: Skin burns and lesions under the electrodes; visual phosphenes and flicker with alternating-current protocols; induction of mania or hypomania; cognitive trade-offs between enhanced and impaired functions; hazards of unregulated consumer and self-built devices
  • Low: Seizure provocation; transient nausea, dizziness and blurred vision; sleep disruption from late-day stimulation
  • Speculative: Unknown consequences of years of repeated home use; diminishing or reversed effects from over-frequent sessions

Monitoring

Marker Target Why
Hemoglobin A1c 4.8–5.4% Chronic glucose elevation accelerates cognitive decline and confounds any attributed benefit
High-sensitivity C-reactive protein <0.5 mg/L Systemic inflammation blunts synaptic plasticity and tracks with poorer cognitive trajectories
Homocysteine 5–7 µmol/L Elevation is one of the few modifiable markers linked to brain atrophy rate and memory decline
Vitamin B12 500–1,000 pg/mL Deficiency produces fully reversible memory and mood complaints that mimic what stimulation is being used for
25-hydroxyvitamin D 40–60 ng/mL Low status associates with poorer cognitive performance and low mood, both target outcomes here
Thyroid-stimulating hormone 0.5–2.0 mIU/L Underactive thyroid mimics depression and cognitive slowing precisely

Cadence: Scalp inspection after every session; symptom and side-effect review at 1 week and 2 weeks; cognitive battery and mood questionnaire at 4–6 weeks and at the end of the course; blood panel at 6 months, then every 6–12 months. Where a mood protocol is running, a weekly self-rated depression and anxiety score for the first 4 weeks.

Qualitative Assessment

  • Word-finding and name recall — the everyday manifestation of the memory domain most responsive in trials
  • Sustained attention on demanding work — how long focused work is possible before quality degrades
  • Mental fatigue after sessions — distinguishing an expected transient heaviness from a persistent decrement
  • Sleep onset latency and early-night awakenings — the earliest signal that session timing is wrong
  • Mood stability and, specifically, reduced sleep need or unusual goal-directed activity — the activation pattern that warrants stopping
  • Scalp comfort and skin appearance at electrode sites — redness resolving within an hour is expected; anything persisting is not
  • Perceived exertion during standard training sessions — relevant if stimulation is being used around exercise
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.